K4 Elite logo K4 Elite
Home / Peptide Library / Cortagen
Emerging Research

Cortagen

Cognitive & Neurological · ['Kortagen', 'Cortical peptide bioregulator', 'Ala-Glu-Asp-Pro (cited tetrapeptide analog)']

A short-peptide bioregulator originally derived from cerebral cortex tissue, studied in Russian gerontology and neuroscience literature for effects on neuronal function and cortical signaling.

🔬 Research use only — not for human or veterinary use. K4 Elite does not provide dosing instructions.
Research Level
Emerging Research
Browse the store →
🧬

Cortagen is one of the Khavinson peptide bioregulators, a class of short peptides and peptide complexes developed in Russia and originally isolated from animal cortical tissue. It belongs to a family of tissue-specific 'cytomax' and synthetic 'cytogen' peptides proposed by their developers to interact with the tissue of origin.

Cortagen is associated in this literature with the cerebral cortex and nervous system. Some sources describe a synthetic tetrapeptide analog (cited as Ala-Glu-Asp-Pro), though the commercial preparation is generally described as a short-peptide complex, so its precise molecular identity is not consistently reported.

Because reliable structural identifiers are not established across sources, molecular fields are left blank here. The material below summarizes the available scientific literature for reference purposes only.

The proposed mechanism in the Khavinson-school literature is 'peptide bioregulation,' in which short peptides are described as binding regulatory regions of DNA and modulating tissue-specific gene expression in the cells from which they were derived. For Cortagen, investigators focus on neuronal and cortical tissue.

These mechanistic descriptions come largely from the developers' own research group and remain areas of ongoing investigation rather than broadly independently confirmed pathways.

  • Neuronal survival and cortical tissue signaling in animal models
  • Peptide bioregulation and tissue-specific gene-expression hypotheses
  • Peripheral nerve regeneration exploratory studies
  • Cognitive and neurophysiological research in aging models
  • Antioxidant and neuroprotective effect investigations
📋 How published studies were conducted — a research reference summarizing study designs from the literature. This is not usage, dosing, or administration guidance. K4 Elite does not provide dosing instructions; determining any research protocol is the sole responsibility of the qualified researcher.

Khavinson and colleagues have published a body of work describing short cortical peptides in animal models of nerve injury and aging, reporting effects on neuronal markers and behavioral measures. These reports originate largely from a single research school and are summarized here strictly as published exploratory findings.

Review articles by Khavinson (e.g., in Bull Exp Biol Med and Neuro Endocrinol Lett) place Cortagen within the broader cytogen peptide framework and describe proposed geroprotective and neurotropic activity observed in laboratory studies.

Combinations examined in the research literature. Descriptive only — not a recommendation to combine compounds.

CerebrolysinNeutral
Both are studied in neuroscience contexts; combined effects are not characterized in the literature.
CerlutenCompatible
Another Khavinson bioregulator studied within the same peptide framework.
Nootropic small moleculesNeutral
Distinct proposed mechanisms; interactions are not well described in study data.
PinealonCompatible
A related short neuropeptide bioregulator studied in overlapping research programs.
  1. Khavinson VK. Peptides and Ageing. Neuro Endocrinol Lett 2002
  2. Khavinson VK, Malinin VV. Gerontological Aspects of Genome Peptide Regulation. Bull Exp Biol Med (monograph)
  3. Khavinson VK et al. Peptide Regulation of Gene Expression: A Systematic Review. Molecules 2021
What is Cortagen?
It is a short-peptide bioregulator from the Khavinson family of tissue-derived peptides, associated in the literature with cerebral cortex and nervous-system research.
Why are the molecular fields blank?
Sources do not consistently report a single verified structure or PubChem identifier for the commercial preparation, so no molecular data is listed rather than risk fabricating identifiers.
How strong is the evidence base?
Most published work originates from a single research school, so Cortagen is best regarded as an emerging-research compound rather than an extensively validated one.
What is a peptide bioregulator?
It refers to a class of short peptides proposed by their developers to influence tissue-specific gene expression; these mechanisms remain under investigation.
Is this material for human or veterinary use?
No. It is supplied strictly as a research-use-only reference material and is not intended for human consumption, medical treatment, or veterinary application.
Disclaimer: This profile summarizes published preclinical and laboratory research for reference only. It is not medical advice and makes no claim of safety or efficacy in humans. Determining any research protocol is the sole responsibility of the qualified researcher. Products are sold strictly for in-vitro research and have not been evaluated by the FDA.